Terry-Ann Burrell, CFO at Beam Therapeutics Inc. (BEAM), sold 48,300 shares at $79.21 ($4.0M) on 2021-01-04, disclosed to the SEC on 2021-01-05.
Open-market sale of $4.0M BEAM by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.05 | 800 | $62K | 1.6% |
| 2 | $79.21 | 1,951 | $155K | 3.9% |
| 3 | $79.21 | 1,951 | $155K | 3.9% |
| 4 | $80.25 | 2,449 | $197K | 5.0% |
| 5 | $80.25 | 2,449 | $197K | 5.0% |
| 6 | $81.26 | 6,509 |
| $529K |
| 13.4% |
| 7 | $81.26 | 6,509 | $529K | 13.4% |
| 8 | $82.44 | 5,296 | $437K | 11.1% |
| 9 | $82.44 | 5,296 | $437K | 11.1% |
| 10 | $83.15 | 7,095 | $590K | 14.9% |
| 11 | $83.15 | 7,095 | $590K | 14.9% |
| 12 | $83.89 | 900 | $76K | 1.9% |
| Total | $81.80 avg | 48,300 | $4.0M | 100% |
| Filing → |
| BEAM | SELL | 2023-04-05 | $276K | — | Filing → |
| BEAM | SELL | 2023-01-30 | $3.3M | — | Filing → |
| BEAM | SELL | 2023-01-25 | $1.8M | — | Filing → |